aguynamedmarco vs King | 19–14 | 57.58% |
aguynamedmarco vs Jin | 13–18 | 41.94% |
aguynamedmarco vs Kazuya | 19–10 | 65.52% |
aguynamedmarco vs Steve | 13–8 | 61.90% |
aguynamedmarco vs Hwoarang | 11–6 | 64.71% |
aguynamedmarco vs Dragunov | 12–3 | 80.00% |
aguynamedmarco vs Yoshimitsu | 11–2 | 84.62% |
aguynamedmarco vs Paul | 5–7 | 41.67% |
aguynamedmarco vs Xiaoyu | 6–6 | 50.00% |
aguynamedmarco vs Bryan | 8–3 | 72.73% |
aguynamedmarco vs Leo | 6–5 | 54.55% |
aguynamedmarco vs Claudio | 8–3 | 72.73% |
aguynamedmarco vs Lee | 5–5 | 50.00% |
aguynamedmarco vs Jun | 5–5 | 50.00% |
aguynamedmarco vs Eddy | 7–3 | 70.00% |
aguynamedmarco vs Law | 4–5 | 44.44% |
aguynamedmarco vs Asuka | 7–2 | 77.78% |
aguynamedmarco vs Lili | 7–1 | 87.50% |
aguynamedmarco vs Azucena | 6–2 | 75.00% |
aguynamedmarco vs Reina | 2–5 | 28.57% |
aguynamedmarco vs Devil Jin | 2–4 | 33.33% |
aguynamedmarco vs Alisa | 4–2 | 66.67% |
aguynamedmarco vs Panda | 2–4 | 33.33% |
aguynamedmarco vs Victor | 4–2 | 66.67% |
aguynamedmarco vs Lars | 2–2 | 50.00% |
aguynamedmarco vs Kuma | 0–4 | 0.00% |
aguynamedmarco vs Leroy | 4–0 | 100.00% |
aguynamedmarco vs Jack-8 | 3–0 | 100.00% |
aguynamedmarco vs Raven | 2–1 | 66.67% |
aguynamedmarco vs Shaheen | 2–0 | 100.00% |
aguynamedmarco vs Zafina | 0–2 | 0.00% |
aguynamedmarco vs Lidia | 0–2 | 0.00% |
aguynamedmarco vs Feng | 1–0 | 100.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.